US20130118949A1 - Dual sterilization containment vessel - Google Patents
Dual sterilization containment vessel Download PDFInfo
- Publication number
- US20130118949A1 US20130118949A1 US13/676,695 US201213676695A US2013118949A1 US 20130118949 A1 US20130118949 A1 US 20130118949A1 US 201213676695 A US201213676695 A US 201213676695A US 2013118949 A1 US2013118949 A1 US 2013118949A1
- Authority
- US
- United States
- Prior art keywords
- containment vessel
- cap
- dual sterilization
- hollow element
- sterilization containment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0095—Packages or dispensers for prostheses or other implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/2436—Deployment by retracting a sheath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/26—Accessories or devices or components used for biocidal treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M39/12—Tube connectors; Tube couplings for joining a flexible tube to a rigid attachment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/243—Deployment by mechanical expansion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M2039/1033—Swivel nut connectors, e.g. threaded connectors, bayonet-connectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0108—Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
- A61M25/0133—Tip steering devices
- A61M25/0136—Handles therefor
Definitions
- the present disclosure pertains to medical devices, and methods for manufacturing medical devices. More particularly, the present disclosure pertains to medical devices for delivering a replacement heart valve.
- intracorporeal medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires, catheters, medical device delivery systems (e.g., for stents, grafts, replacement valves, etc.), and the like. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.
- This disclosure pertains to a sealable dual sterilization containment vessel for biologically derived medical components
- a sealable dual sterilization containment vessel for biologically derived medical components comprising a hollow element having a wall, a proximal end, a distal end, and a lumen therebetween, said lumen configured and adapted to contain a biologically derived medical component and at least a portion of an apparatus configured and adapted to implant the biologically derived medical component in a living body; a distal end cap; a proximal end cap; and a radiopaque sleeve, wherein the proximal end cap has a secondary proximal end cap and ferrule sized and adapted to and capable of reversibly sealing the proximal end cap to a delivery catheter passing therethrough, further wherein the combination of the hollow element, the distal end cap, the proximal end cap, the secondary proximal end cap, the ferrule, and the delivery catheter form a fluid tight system providing a continuous fluid
- the disclosure relates to a sealed system for delivering a replacement heart valve comprising a replacement heart valve; a delivery catheter; and elements configured and adapted to position and install the replacement heart valve; the system further comprising a storage and shipping container, wherein at least the replacement heart valve and a portion of the elements configured and adapted to position and install the replacement heart valve are initially contained within a fluid filled removable dual sterilization containment vessel.
- the biologically derived component(s) of the replacement heart valve may be maintained in a hydrated state within the provided sterile system environment during storage and shipping.
- FIG. 1 illustrates an exemplary replacement heart valve delivery system and associated packaging.
- FIG. 2 illustrates a replacement heart valve and associated components which may be used with the dual sterilization containment vessel disclosed herein
- FIG. 3 illustrates a dual sterilization containment vessel of the disclosure.
- FIGS. 4A and 4B illustrate partially exploded views of the dual sterilization containment vessel of FIG. 3 .
- FIG. 5 illustrates an embodiment of a hollow element of an embodiment of the disclosure.
- references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc. indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an embodiment, it would be within the knowledge of one skilled in the art to effect such feature, structure, or characteristic in connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.
- FIG. 1 illustrates a system 10 for delivering a replacement heart valve and packaging 40 associated therewith.
- the heart valve replacement system 10 may comprise a replacement heart valve 12 , having a biologically derived component 16 , and associated components 14 ( FIG. 2 ) configured and adapted to position and install the replacement heart valve 12 .
- These components may be any of the replacement heart valves and associated components known in the art and the specifics thereof need not be discussed in detail to understand the operation of the system.
- the non-limiting exemplary replacement heart valve 12 may be a valve including one or more biologically derived components and may, for example, be derived from treated human, bovine, or porcine tissue.
- the system 10 for delivering a replacement heart valve also may include additional components such as a control handle 20 , a delivery catheter 30 and a dual sterilization containment vessel 50 which is configured and adapted to contain at least one biocidal fluid (not shown), which biocidal fluid may also be contained within the delivery catheter 20 and in fluid contact therewith.
- the biocidal fluid may contain, for example, gluteraldehyde which serves to sterilize the contacted surfaces of the system and which optionally may tend to cross-link biologically derived components of the replacement heart valve.
- FIGS. 3 , 4 A, and 4 B illustrate various components of a dual sterilization containment vessel 50 which is configured and adapted to contain at least one biocidal fluid.
- a dual sterilization containment vessel 50 will be understood to encompass a vessel which is configured and adapted to contain at least one sterilizing biocidal fluid as well as to allow ionizing radiation sterilization of the contents of the vessel and other components of a replacement heart valve delivery system without undue damage to the biologically derived components 16 of the replacement heart valve 12 .
- this may be accomplished by selecting construction materials which are substantially unreactive with the contacting biocide(s) and further by including as a component the dual sterilization containment vessel 50 a radiopaque sleeve 90 which prevents excessive levels of ionizing radiation which may be applied to the remaining components of the system 10 for delivering a replacement heart valve from reaching and damaging the biologically derived components.
- the radiopaque sleeve 90 may be removable or may be permanently attached to one or more other components of the dual sterilization containment vessel 50 .
- the radiopaque sleeve 90 may be contained within the sterilization containment vessel 50 to ensure that the space between an external radiopaque sleeve 90 and the sterilization containment vessel 50 remains sterile.
- the joins between an external radiopaque sleeve 90 and the sterilization containment vessel 50 may be sealed, for example by an O-ring, gasket, sealant, or the like to isolate the space between an external radiopaque sleeve 90 and the sterilization containment vessel 50 and maintain a sterile environment therebetween.
- the external radiopaque sleeve 90 and the sterilization containment vessel 50 may be integrally formed to eliminate an exposed interface which might harbor contamination.
- a dual sterilization containment vessel 50 is particularly desirable when other components of the system 10 for delivering a replacement heart valve 12 require exposure of the system as a whole to high levels of ionizing radiation to ensure that biocidal dosage levels are delivered to all internal parts of the system. Further, the use of two separate sterilization methods, enabled by the presence of a dual sterilization containment vessel 50 within the system is believed to substantially reduce the risk of bioactive contamination.
- FIGS. 3 , 4 A, and 4 B illustrate a hollow element 80 having a wall, a proximal end, a distal end, and a lumen therebetween, said lumen configured and adapted to contain a biologically derived medical component 16 and at least a portion of an apparatus 14 configured and adapted to position and implant the biologically derived medical component 16 in a living body; a distal end cap 60 ; a proximal end cap 70 wherein the proximal end cap 70 has a secondary proximal end cap 72 and ferrule 74 sized and adapted to and capable of reversibly sealing the proximal end cap 70 to a delivery catheter 30 passing therethrough.
- the combination of the hollow element 80 , the distal end cap 60 , the proximal end cap 70 , the secondary proximal end cap 72 , the ferrule 74 , delivery catheter 30 , and handle 20 form a fluid tight system providing a continuous fluid connection between the interior of the hollow element 80 and the lumen of the delivery catheter 30 .
- the hollow element 80 , and/or the distal end cap 60 may include a stopcock 82 to facilitate filling and draining biocide (s) from the system prior to removal of the dual sterilization containment vessel 50 .
- Hollow element 80 comprises a hollow body having sufficient internal volume to contain the replacement heart valve and at least a portion of the associated components 14 configured and adapted to position and install the replacement heart valve 12 .
- the replacement heart valve 12 and associated components 14 configured and adapted to position and install the replacement heart valve 12 are stored in at least a somewhat expanded configuration which may more fully expose their components to the biocidal fluid contained therein.
- the hollow element 80 may have a rectangular or other cross-section if desired.
- Hollow element 80 is depicted as having a unitary construction, however in some embodiments the hollow body may be fabricated in two or more segments which are suitably sealed when joined.
- the hollow body may be formed from two half-cylindrical walls joined along a separable longitudinal seam, such as a clam-shell arrangement, with an appropriate gasket therebetween.
- hollow body 80 may include stopcock 82 .
- construction materials which are substantially unreactive with the contacting biocide(s), such as polycarbonate, may be used for the hollow element 80 and other components of the dual sterilization containment vessel 50 .
- Such materials may be selected to be partially or fully transparent to visible light thereby allowing visual inspection of the contents.
- the materials should remain substantially unchanged chemically and mechanically upon absorption of ionizing radiation at levels of 30, 40, 50 gray, or in some embodiments more whether empty or filled with a biocidal fluid.
- hollow element 80 may include a polished surface in fluid communication with the interior of the hollow element which is believed to facilitate removal of bubbles from the biocidal fluid within the dual sterilization containment vessel 50 .
- hollow element 80 may include one or more features configured and adapted to direct the motion of any bubbles which may be present within the dual sterilization containment vessel 50 when it is filled with fluid and subject to changes in orientation. Such features may include ridges, grooves, and/or tapers.
- distal cap 60 and proximal cap 70 may be secured to hollow element 80 by mating threaded sections. Other means of reversible attachment may also be used.
- the illustrated embodiment depicts male threads 84 , 86 on the hollow body 80 and corresponding female threads on the end caps 60 , 70 , it will be appreciated that a cap may be provided with male threads and the hollow body with female threads at one or both ends of the dual sterilization containment vessel 50 .
- Proximal end cap 70 may include a secondary proximal end cap 72 which together with ferrule 74 acts to seal the dual sterilization containment vessel 50 to other parts, indicated by reference numeral 30 , of the illustrated system 10 for delivering a replacement heart valve 12 while maintaining a fluid connection with the lumen or lumens thereof.
- Removable radiopaque sleeve 90 will typically have an internal lumen which substantially matches the exterior shape and dimension of the hollow element 80 .
- the radiopaque sleeve 90 may comprise a radiopaque solid or a radiopaque fluid or gel.
- Radiopaque sleeve 90 optionally may be secured to the hollow element 80 by, for example, set screw 92 during a portion of the sterilization process.
- the radiopaque sleeve may be formed from several pieces and held in place by a clamping element (not shown). In such embodiments, the pieces may include overlapping regions along the joins to ensure that higher than desirable ionizing radiation does not reach biologically derived components 16 .
- the radiopaque sleeve 90 may be permanently attached to one or more of the other components of dual sterilization containment vessel 50 .
- the radiopacity of the combined radiopaque sleeve 90 may be selected such that in combination with hollow body 80 , the biologically derived medical component 16 absorbs no more than 4 gray when the dual sterilization containment vessel 50 absorbs 30, 40, 50 gray, or in some embodiments more whether the dual sterilization containment vessel 50 is empty or filled with a biocidal fluid.
- distal cap 60 and proximal cap 70 may be sized and configured to retain radiopaque sleeve 90 in position about hollow element 80
- the radiopaque sleeve 90 may be configured to be removable from the hollow element 80 without removing one or both of the end caps.
- a set screw 94 or other retaining device may be employed.
- a dual sterilization containment vessel 50 may be described as follows.
- Replacement heart valve 12 and associated components 14 configured and adapted to position and install the replacement heart valve 12 may be withdrawn within delivery catheter 30 , whereupon an assembled dual sterilization containment vessel 50 may be positioned to partially encompass the distal end of the delivery catheter 30 .
- proximal end cap 70 is secured to the distal end of delivery catheter 30 by secondary proximal end cap 72 and ferrule 74
- replacement heart valve 10 and associated components 14 configured and adapted to position and install the replacement heart valve 12 may be advanced from the distal end of delivery catheter 30 until it achieves an expanded configuration such as that of FIG. 2 .
- Continuous lumen(s) joining handle 20 , delivery catheter 30 , and dual sterilization containment vessel 50 may then be filled with a biocidal fluid, such as an alcoholic gluteraldehyde solution, and flushed to remove bubbles and any incidentally introduced debris.
- a biocidal fluid such as an alcoholic gluteraldehyde solution
- stopcock 82 and a corresponding stopcock associated with handle 20 may be closed to seal and contain the biocidal fluid within the now closed system.
- the closed system may be placed in packaging 40 and exposed to a source of ionizing radiation of sufficient penetrating power and for a sufficient time to sterilize the contents of packaging 40 .
- Radiopaque sleeve 90 serves to limit the radiation absorbed by the biologically derived component(s) 16 .
- the radiation absorbed by biologically derived component(s) 16 will be less than 4 gray when the system as a whole has absorbed 30, 40, 50 gray, or in some embodiments more.
- the dual sterilization containment vessel 50 is configured and adapted to maintain the biologically derived medical component(s) in a hydrating and sterile environment prior to use.
- the illustrative examples described herein relate to replacement heart valves
- use of the dual sterilization containment vessel with other biologically derived medical components is also contemplated.
- the biologically derived medical component may be present in the form of a different valve structure, stent graft, or the like.
- Dual sterilization containment vessels for such applications may require modifications in size, shape and/or materials.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Prostheses (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Packages (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
- The present disclosure pertains to medical devices, and methods for manufacturing medical devices. More particularly, the present disclosure pertains to medical devices for delivering a replacement heart valve.
- A wide variety of intracorporeal medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires, catheters, medical device delivery systems (e.g., for stents, grafts, replacement valves, etc.), and the like. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.
- This disclosure pertains to a sealable dual sterilization containment vessel for biologically derived medical components comprising a hollow element having a wall, a proximal end, a distal end, and a lumen therebetween, said lumen configured and adapted to contain a biologically derived medical component and at least a portion of an apparatus configured and adapted to implant the biologically derived medical component in a living body; a distal end cap; a proximal end cap; and a radiopaque sleeve, wherein the proximal end cap has a secondary proximal end cap and ferrule sized and adapted to and capable of reversibly sealing the proximal end cap to a delivery catheter passing therethrough, further wherein the combination of the hollow element, the distal end cap, the proximal end cap, the secondary proximal end cap, the ferrule, and the delivery catheter form a fluid tight system providing a continuous fluid connection between the interior of the hollow element and the lumen of the delivery catheter.
- In another embodiment, the disclosure relates to a sealed system for delivering a replacement heart valve comprising a replacement heart valve; a delivery catheter; and elements configured and adapted to position and install the replacement heart valve; the system further comprising a storage and shipping container, wherein at least the replacement heart valve and a portion of the elements configured and adapted to position and install the replacement heart valve are initially contained within a fluid filled removable dual sterilization containment vessel. The biologically derived component(s) of the replacement heart valve may be maintained in a hydrated state within the provided sterile system environment during storage and shipping.
-
FIG. 1 illustrates an exemplary replacement heart valve delivery system and associated packaging. -
FIG. 2 illustrates a replacement heart valve and associated components which may be used with the dual sterilization containment vessel disclosed herein -
FIG. 3 illustrates a dual sterilization containment vessel of the disclosure. -
FIGS. 4A and 4B illustrate partially exploded views of the dual sterilization containment vessel ofFIG. 3 . -
FIG. 5 illustrates an embodiment of a hollow element of an embodiment of the disclosure. - The following description should be read with reference to the drawings wherein like reference numerals indicate like elements throughout the several views. The drawings, which are not necessarily to scale, are not intended to limit the scope of the claimed invention. The detailed description and drawings illustrate example embodiments of the claimed invention.
- All numbers are herein assumed to be modified by the term “about.” The recitation of numerical ranges by endpoints includes all numbers subsumed within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
- As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include the plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
- It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an embodiment, it would be within the knowledge of one skilled in the art to effect such feature, structure, or characteristic in connection with other embodiments whether or not explicitly described unless clearly stated to the contrary.
-
FIG. 1 illustrates asystem 10 for delivering a replacement heart valve and packaging 40 associated therewith. The heartvalve replacement system 10 may comprise areplacement heart valve 12, having a biologically derivedcomponent 16, and associated components 14 (FIG. 2 ) configured and adapted to position and install thereplacement heart valve 12. These components may be any of the replacement heart valves and associated components known in the art and the specifics thereof need not be discussed in detail to understand the operation of the system. The non-limiting exemplaryreplacement heart valve 12 may be a valve including one or more biologically derived components and may, for example, be derived from treated human, bovine, or porcine tissue. Thesystem 10 for delivering a replacement heart valve also may include additional components such as acontrol handle 20, adelivery catheter 30 and a dualsterilization containment vessel 50 which is configured and adapted to contain at least one biocidal fluid (not shown), which biocidal fluid may also be contained within thedelivery catheter 20 and in fluid contact therewith. The biocidal fluid may contain, for example, gluteraldehyde which serves to sterilize the contacted surfaces of the system and which optionally may tend to cross-link biologically derived components of the replacement heart valve. -
FIGS. 3 , 4A, and 4B illustrate various components of a dualsterilization containment vessel 50 which is configured and adapted to contain at least one biocidal fluid. A dualsterilization containment vessel 50 will be understood to encompass a vessel which is configured and adapted to contain at least one sterilizing biocidal fluid as well as to allow ionizing radiation sterilization of the contents of the vessel and other components of a replacement heart valve delivery system without undue damage to the biologically derivedcomponents 16 of thereplacement heart valve 12. - In some embodiments, this may be accomplished by selecting construction materials which are substantially unreactive with the contacting biocide(s) and further by including as a component the dual sterilization containment vessel 50 a
radiopaque sleeve 90 which prevents excessive levels of ionizing radiation which may be applied to the remaining components of thesystem 10 for delivering a replacement heart valve from reaching and damaging the biologically derived components. Theradiopaque sleeve 90 may be removable or may be permanently attached to one or more other components of the dualsterilization containment vessel 50. In certain embodiments, theradiopaque sleeve 90 may be contained within thesterilization containment vessel 50 to ensure that the space between anexternal radiopaque sleeve 90 and thesterilization containment vessel 50 remains sterile. In certain other embodiments, the joins between anexternal radiopaque sleeve 90 and thesterilization containment vessel 50 may be sealed, for example by an O-ring, gasket, sealant, or the like to isolate the space between anexternal radiopaque sleeve 90 and thesterilization containment vessel 50 and maintain a sterile environment therebetween. In yet other embodiments, theexternal radiopaque sleeve 90 and thesterilization containment vessel 50 may be integrally formed to eliminate an exposed interface which might harbor contamination. - The use of a dual
sterilization containment vessel 50 is particularly desirable when other components of thesystem 10 for delivering areplacement heart valve 12 require exposure of the system as a whole to high levels of ionizing radiation to ensure that biocidal dosage levels are delivered to all internal parts of the system. Further, the use of two separate sterilization methods, enabled by the presence of a dualsterilization containment vessel 50 within the system is believed to substantially reduce the risk of bioactive contamination. -
FIGS. 3 , 4A, and 4B illustrate ahollow element 80 having a wall, a proximal end, a distal end, and a lumen therebetween, said lumen configured and adapted to contain a biologically derivedmedical component 16 and at least a portion of anapparatus 14 configured and adapted to position and implant the biologically derivedmedical component 16 in a living body; adistal end cap 60; aproximal end cap 70 wherein theproximal end cap 70 has a secondaryproximal end cap 72 andferrule 74 sized and adapted to and capable of reversibly sealing theproximal end cap 70 to adelivery catheter 30 passing therethrough. Further, the combination of thehollow element 80, thedistal end cap 60, theproximal end cap 70, the secondaryproximal end cap 72, theferrule 74,delivery catheter 30, and handle 20 form a fluid tight system providing a continuous fluid connection between the interior of thehollow element 80 and the lumen of thedelivery catheter 30. In some embodiments, thehollow element 80, and/or thedistal end cap 60, may include astopcock 82 to facilitate filling and draining biocide (s) from the system prior to removal of the dualsterilization containment vessel 50. -
Hollow element 80, illustrated in greater detail inFIG. 5 , comprises a hollow body having sufficient internal volume to contain the replacement heart valve and at least a portion of the associatedcomponents 14 configured and adapted to position and install thereplacement heart valve 12. In some embodiments, thereplacement heart valve 12 and associatedcomponents 14 configured and adapted to position and install thereplacement heart valve 12 are stored in at least a somewhat expanded configuration which may more fully expose their components to the biocidal fluid contained therein. Although illustrated as generally cylindrical, it will be appreciated thehollow element 80 may have a rectangular or other cross-section if desired.Hollow element 80 is depicted as having a unitary construction, however in some embodiments the hollow body may be fabricated in two or more segments which are suitably sealed when joined. For example, the hollow body may be formed from two half-cylindrical walls joined along a separable longitudinal seam, such as a clam-shell arrangement, with an appropriate gasket therebetween. In some embodiments,hollow body 80 may includestopcock 82. - As noted herein, construction materials which are substantially unreactive with the contacting biocide(s), such as polycarbonate, may be used for the
hollow element 80 and other components of the dualsterilization containment vessel 50. Such materials may be selected to be partially or fully transparent to visible light thereby allowing visual inspection of the contents. In addition, the materials should remain substantially unchanged chemically and mechanically upon absorption of ionizing radiation at levels of 30, 40, 50 gray, or in some embodiments more whether empty or filled with a biocidal fluid. In certain embodiments, at least a portion of the interior of at least one of thehollow element 80, thedistal cap 60, and theproximal cap 70 may include a polished surface in fluid communication with the interior of the hollow element which is believed to facilitate removal of bubbles from the biocidal fluid within the dualsterilization containment vessel 50. In addition,hollow element 80 may include one or more features configured and adapted to direct the motion of any bubbles which may be present within the dualsterilization containment vessel 50 when it is filled with fluid and subject to changes in orientation. Such features may include ridges, grooves, and/or tapers. - As illustrated,
distal cap 60 andproximal cap 70 may be secured tohollow element 80 by mating threaded sections. Other means of reversible attachment may also be used. Although the illustrated embodiment depictsmale threads hollow body 80 and corresponding female threads on theend caps sterilization containment vessel 50. -
Proximal end cap 70 may include a secondaryproximal end cap 72 which together withferrule 74 acts to seal the dualsterilization containment vessel 50 to other parts, indicated byreference numeral 30, of the illustratedsystem 10 for delivering areplacement heart valve 12 while maintaining a fluid connection with the lumen or lumens thereof. - Removable
radiopaque sleeve 90 will typically have an internal lumen which substantially matches the exterior shape and dimension of thehollow element 80. Theradiopaque sleeve 90 may comprise a radiopaque solid or a radiopaque fluid or gel.Radiopaque sleeve 90 optionally may be secured to thehollow element 80 by, for example, setscrew 92 during a portion of the sterilization process. In the alternative, the radiopaque sleeve may be formed from several pieces and held in place by a clamping element (not shown). In such embodiments, the pieces may include overlapping regions along the joins to ensure that higher than desirable ionizing radiation does not reach biologically derivedcomponents 16. In yet other embodiments, theradiopaque sleeve 90 may be permanently attached to one or more of the other components of dualsterilization containment vessel 50. The radiopacity of the combinedradiopaque sleeve 90 may be selected such that in combination withhollow body 80, the biologically derivedmedical component 16 absorbs no more than 4 gray when the dualsterilization containment vessel 50 absorbs 30, 40, 50 gray, or in some embodiments more whether the dualsterilization containment vessel 50 is empty or filled with a biocidal fluid. - Although one or both of
distal cap 60 andproximal cap 70 may be sized and configured to retainradiopaque sleeve 90 in position abouthollow element 80, it will be appreciated that in some embodiments, theradiopaque sleeve 90 may be configured to be removable from thehollow element 80 without removing one or both of the end caps. In such embodiments, a set screw 94 or other retaining device may be employed. - One possible, non-limiting, use sequence for a dual
sterilization containment vessel 50 may be described as follows.Replacement heart valve 12 and associatedcomponents 14 configured and adapted to position and install thereplacement heart valve 12 may be withdrawn withindelivery catheter 30, whereupon an assembled dualsterilization containment vessel 50 may be positioned to partially encompass the distal end of thedelivery catheter 30. Onceproximal end cap 70 is secured to the distal end ofdelivery catheter 30 by secondaryproximal end cap 72 andferrule 74,replacement heart valve 10 and associatedcomponents 14 configured and adapted to position and install thereplacement heart valve 12 may be advanced from the distal end ofdelivery catheter 30 until it achieves an expanded configuration such as that ofFIG. 2 . Continuous lumen(s) joininghandle 20,delivery catheter 30, and dualsterilization containment vessel 50 may then be filled with a biocidal fluid, such as an alcoholic gluteraldehyde solution, and flushed to remove bubbles and any incidentally introduced debris. Following flushing,stopcock 82 and a corresponding stopcock associated withhandle 20 may be closed to seal and contain the biocidal fluid within the now closed system. - The closed system may be placed in
packaging 40 and exposed to a source of ionizing radiation of sufficient penetrating power and for a sufficient time to sterilize the contents ofpackaging 40.Radiopaque sleeve 90 serves to limit the radiation absorbed by the biologically derived component(s) 16. In some embodiments, the radiation absorbed by biologically derived component(s) 16 will be less than 4 gray when the system as a whole has absorbed 30, 40, 50 gray, or in some embodiments more. At this point, it will be appreciated that the contents of the system have been sterilized by two independent methods and is ready for storage and distribution prior to use in a heart valve replacement procedure. The dualsterilization containment vessel 50 is configured and adapted to maintain the biologically derived medical component(s) in a hydrating and sterile environment prior to use. - Although the illustrative examples described herein relate to replacement heart valves, use of the dual sterilization containment vessel with other biologically derived medical components is also contemplated. In such an embodiment, the biologically derived medical component may be present in the form of a different valve structure, stent graft, or the like. Dual sterilization containment vessels for such applications may require modifications in size, shape and/or materials.
- Various modifications and alterations of this invention will become apparent to those skilled in the art without departing from the scope and principles of this invention, and it should be understood that this invention is not to be unduly limited to the illustrative embodiments set forth hereinabove. All publications and patents are herein incorporated by reference to the same extent as if each individual publication or patent was specifically and individually indicated to be incorporated by reference.
Claims (20)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/676,695 US8851286B2 (en) | 2011-11-15 | 2012-11-14 | Dual sterilization containment vessel |
EP12799385.5A EP2780042B1 (en) | 2011-11-15 | 2012-11-15 | Dual sterilization containment vessel |
JP2014542456A JP2015505683A (en) | 2011-11-15 | 2012-11-15 | Double sterile containment |
CA2856072A CA2856072C (en) | 2011-11-15 | 2012-11-15 | Dual sterilization containment vessel |
CN201280067156.0A CN104053456B (en) | 2011-11-15 | 2012-11-15 | Double sterilization containers |
PCT/US2012/065250 WO2013074771A1 (en) | 2011-11-15 | 2012-11-15 | Dual sterilization containment vessel |
US14/483,598 US9707077B2 (en) | 2011-11-15 | 2014-09-11 | Dual sterilization containment vessel |
US15/623,805 US10849744B2 (en) | 2011-11-15 | 2017-06-15 | Dual sterilization containment vessel |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161559914P | 2011-11-15 | 2011-11-15 | |
US13/676,695 US8851286B2 (en) | 2011-11-15 | 2012-11-14 | Dual sterilization containment vessel |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/483,598 Continuation US9707077B2 (en) | 2011-11-15 | 2014-09-11 | Dual sterilization containment vessel |
Publications (2)
Publication Number | Publication Date |
---|---|
US20130118949A1 true US20130118949A1 (en) | 2013-05-16 |
US8851286B2 US8851286B2 (en) | 2014-10-07 |
Family
ID=48279588
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/676,695 Active 2033-04-11 US8851286B2 (en) | 2011-11-15 | 2012-11-14 | Dual sterilization containment vessel |
US14/483,598 Active 2033-06-10 US9707077B2 (en) | 2011-11-15 | 2014-09-11 | Dual sterilization containment vessel |
US15/623,805 Active 2033-10-01 US10849744B2 (en) | 2011-11-15 | 2017-06-15 | Dual sterilization containment vessel |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/483,598 Active 2033-06-10 US9707077B2 (en) | 2011-11-15 | 2014-09-11 | Dual sterilization containment vessel |
US15/623,805 Active 2033-10-01 US10849744B2 (en) | 2011-11-15 | 2017-06-15 | Dual sterilization containment vessel |
Country Status (6)
Country | Link |
---|---|
US (3) | US8851286B2 (en) |
EP (1) | EP2780042B1 (en) |
JP (1) | JP2015505683A (en) |
CN (1) | CN104053456B (en) |
CA (1) | CA2856072C (en) |
WO (1) | WO2013074771A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017197054A1 (en) * | 2016-05-13 | 2017-11-16 | Boston Scientific Scimed, Inc. | Containment vessel with implant sheathing guide |
US9987133B2 (en) | 2008-02-26 | 2018-06-05 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
CN109939346A (en) * | 2019-04-26 | 2019-06-28 | 深圳安特医疗股份有限公司 | Protective cap |
WO2019217364A1 (en) * | 2018-05-07 | 2019-11-14 | Medtronic Vascular, Inc. | Assemblies and methods of sterilizing a wet stored implant |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1951352B1 (en) | 2005-11-10 | 2017-01-11 | Edwards Lifesciences CardiAQ LLC | Balloon-expandable, self-expanding, vascular prosthesis connecting stent |
EP2617388B2 (en) * | 2008-10-10 | 2019-11-06 | Boston Scientific Scimed, Inc. | Medical devices and delivery systems for delivering medical devices |
US9730790B2 (en) | 2009-09-29 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Replacement valve and method |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US9681951B2 (en) | 2013-03-14 | 2017-06-20 | Edwards Lifesciences Cardiaq Llc | Prosthesis with outer skirt and anchors |
US9730791B2 (en) | 2013-03-14 | 2017-08-15 | Edwards Lifesciences Cardiaq Llc | Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
USD755384S1 (en) | 2014-03-05 | 2016-05-03 | Edwards Lifesciences Cardiaq Llc | Stent |
CA3007670A1 (en) | 2016-01-29 | 2017-08-03 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
US11324580B2 (en) | 2016-04-14 | 2022-05-10 | Nuvasive, Inc. | Sterile packaging container |
US10350062B2 (en) | 2016-07-21 | 2019-07-16 | Edwards Lifesciences Corporation | Replacement heart valve prosthesis |
CA3042588A1 (en) | 2016-11-21 | 2018-05-24 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
WO2018204455A1 (en) * | 2017-05-02 | 2018-11-08 | Medtronic Vascular Inc. | Assemblies and methods for sterilizing a wet stored prosthetic heart valve |
WO2018204445A1 (en) | 2017-05-02 | 2018-11-08 | Medtronic Vascular Inc. | Packaging for dry tissue prosthetic heart valve |
AU2018304128B2 (en) | 2017-07-17 | 2021-04-08 | Anteris Technologies Corporation | Sterilized packaging system for catheter |
US10918473B2 (en) * | 2017-07-18 | 2021-02-16 | Edwards Lifesciences Corporation | Transcatheter heart valve storage container and crimping mechanism |
CN111263622A (en) | 2017-08-25 | 2020-06-09 | 内奥瓦斯克迪亚拉公司 | Sequentially deployed transcatheter mitral valve prosthesis |
EP3720390B1 (en) | 2018-01-25 | 2024-05-01 | Edwards Lifesciences Corporation | Delivery system for aided replacement valve recapture and repositioning post- deployment |
CA3118599A1 (en) | 2018-11-08 | 2020-05-14 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
JP7430732B2 (en) | 2019-03-08 | 2024-02-13 | ニオバスク ティアラ インコーポレイテッド | Retrievable prosthesis delivery system |
CA3135753C (en) | 2019-04-01 | 2023-10-24 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
US11491006B2 (en) | 2019-04-10 | 2022-11-08 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
EP3972673A4 (en) | 2019-05-20 | 2023-06-07 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
US11311376B2 (en) | 2019-06-20 | 2022-04-26 | Neovase Tiara Inc. | Low profile prosthetic mitral valve |
USD1022195S1 (en) * | 2021-08-30 | 2024-04-09 | Dcstar Inc | Dredge device |
WO2023124546A1 (en) * | 2021-12-30 | 2023-07-06 | 杭州启明医疗器械股份有限公司 | Holder, packaging box, and packaging system for prosthetic valve |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6416547B1 (en) * | 1999-10-06 | 2002-07-09 | Edwards Lifesciences Corporation | Heart valve carrier and rinse cage |
US7389874B2 (en) * | 2004-07-19 | 2008-06-24 | St. Jude Medical, Inc. | Heart valve support and storing lid system and methods associated therewith |
US20090008279A1 (en) * | 2006-01-20 | 2009-01-08 | Allan Tanghoej | Container For Medical Devices |
US7699168B2 (en) * | 2004-10-29 | 2010-04-20 | Medtronic, Inc. | Heart valve storage and shipping retainer |
US20120290079A1 (en) * | 2011-05-12 | 2012-11-15 | Edwards Lifesciences Corporation | Mitral heart valve holder and storage system |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3834394A (en) * | 1969-11-21 | 1974-09-10 | R Sessions | Occlusion device and method and apparatus for inserting the same |
US5554127A (en) * | 1994-10-11 | 1996-09-10 | Sherwood Medical Company | Syringe needle thimble cap and method of use thereof |
US7137184B2 (en) | 2002-09-20 | 2006-11-21 | Edwards Lifesciences Corporation | Continuous heart valve support frame and method of manufacture |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
EP2529696B1 (en) | 2003-12-23 | 2014-01-29 | Sadra Medical, Inc. | Repositionable heart valve |
US8052749B2 (en) | 2003-12-23 | 2011-11-08 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US20050137691A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Two piece heart valve and anchor |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US20050137686A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical, A Delaware Corporation | Externally expandable heart valve anchor and method |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US20050137696A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Apparatus and methods for protecting against embolization during endovascular heart valve replacement |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
CN101415379B (en) | 2006-02-14 | 2012-06-20 | 萨德拉医学公司 | Systems for delivering a medical implant |
US7998404B2 (en) | 2006-07-13 | 2011-08-16 | Advanced Cardiovascular Systems, Inc. | Reduced temperature sterilization of stents |
EP2617388B2 (en) | 2008-10-10 | 2019-11-06 | Boston Scientific Scimed, Inc. | Medical devices and delivery systems for delivering medical devices |
CN101919750A (en) | 2009-03-30 | 2010-12-22 | 卡迪万蒂奇医药公司 | There is not the implantation method of sewing up cusps of pulmonary valve or mitral valve |
US9066785B2 (en) | 2009-04-06 | 2015-06-30 | Medtronic Vascular, Inc. | Packaging systems for percutaneously deliverable bioprosthetic valves |
US9539081B2 (en) * | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
-
2012
- 2012-11-14 US US13/676,695 patent/US8851286B2/en active Active
- 2012-11-15 EP EP12799385.5A patent/EP2780042B1/en not_active Not-in-force
- 2012-11-15 CA CA2856072A patent/CA2856072C/en not_active Expired - Fee Related
- 2012-11-15 CN CN201280067156.0A patent/CN104053456B/en not_active Expired - Fee Related
- 2012-11-15 WO PCT/US2012/065250 patent/WO2013074771A1/en active Application Filing
- 2012-11-15 JP JP2014542456A patent/JP2015505683A/en active Pending
-
2014
- 2014-09-11 US US14/483,598 patent/US9707077B2/en active Active
-
2017
- 2017-06-15 US US15/623,805 patent/US10849744B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6416547B1 (en) * | 1999-10-06 | 2002-07-09 | Edwards Lifesciences Corporation | Heart valve carrier and rinse cage |
US7389874B2 (en) * | 2004-07-19 | 2008-06-24 | St. Jude Medical, Inc. | Heart valve support and storing lid system and methods associated therewith |
US7699168B2 (en) * | 2004-10-29 | 2010-04-20 | Medtronic, Inc. | Heart valve storage and shipping retainer |
US20090008279A1 (en) * | 2006-01-20 | 2009-01-08 | Allan Tanghoej | Container For Medical Devices |
US20120290079A1 (en) * | 2011-05-12 | 2012-11-15 | Edwards Lifesciences Corporation | Mitral heart valve holder and storage system |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11517431B2 (en) | 2005-01-20 | 2022-12-06 | Jenavalve Technology, Inc. | Catheter system for implantation of prosthetic heart valves |
US11357624B2 (en) | 2007-04-13 | 2022-06-14 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US11154398B2 (en) | 2008-02-26 | 2021-10-26 | JenaValve Technology. Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9987133B2 (en) | 2008-02-26 | 2018-06-05 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US10154901B2 (en) | 2008-02-26 | 2018-12-18 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US10702382B2 (en) | 2008-02-26 | 2020-07-07 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11564794B2 (en) | 2008-02-26 | 2023-01-31 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US10993805B2 (en) | 2008-02-26 | 2021-05-04 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US11589981B2 (en) | 2010-05-25 | 2023-02-28 | Jenavalve Technology, Inc. | Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent |
US11185405B2 (en) | 2013-08-30 | 2021-11-30 | Jenavalve Technology, Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
US11337800B2 (en) | 2015-05-01 | 2022-05-24 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US10245136B2 (en) | 2016-05-13 | 2019-04-02 | Boston Scientific Scimed Inc. | Containment vessel with implant sheathing guide |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
WO2017197054A1 (en) * | 2016-05-13 | 2017-11-16 | Boston Scientific Scimed, Inc. | Containment vessel with implant sheathing guide |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
WO2019217364A1 (en) * | 2018-05-07 | 2019-11-14 | Medtronic Vascular, Inc. | Assemblies and methods of sterilizing a wet stored implant |
US11154389B2 (en) | 2018-05-07 | 2021-10-26 | Medtronic Vascular, Inc. | Assemblies and methods of sterilizing a wet stored implant |
CN112055573A (en) * | 2018-05-07 | 2020-12-08 | 美敦力瓦斯科尔勒公司 | Assembly and method for sterilizing wet storage implants |
US11766322B2 (en) | 2018-05-07 | 2023-09-26 | Medtronic Vascular, Inc. | Assemblies and methods of sterilizing a wet stored implant |
CN109939346A (en) * | 2019-04-26 | 2019-06-28 | 深圳安特医疗股份有限公司 | Protective cap |
Also Published As
Publication number | Publication date |
---|---|
CN104053456A (en) | 2014-09-17 |
EP2780042B1 (en) | 2016-03-09 |
US10849744B2 (en) | 2020-12-01 |
US20170281329A1 (en) | 2017-10-05 |
CA2856072C (en) | 2020-05-12 |
US8851286B2 (en) | 2014-10-07 |
CN104053456B (en) | 2016-12-28 |
US20150005873A1 (en) | 2015-01-01 |
WO2013074771A1 (en) | 2013-05-23 |
JP2015505683A (en) | 2015-02-26 |
US9707077B2 (en) | 2017-07-18 |
EP2780042A1 (en) | 2014-09-24 |
CA2856072A1 (en) | 2013-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10849744B2 (en) | Dual sterilization containment vessel | |
KR102442370B1 (en) | Individually sealed disinfectant applicators | |
US9220866B2 (en) | Package with catheter | |
CN107812286B (en) | Port and surface cleaning apparatus and techniques | |
EP2450076B1 (en) | Package with catheter | |
US20070061008A1 (en) | Two-Part Package For Medical Implant | |
EP4275735A3 (en) | Prosthetic heart valve delivery systems and packaging | |
JP2010516342A (en) | Nested sterilization protection cap for isolated connectors | |
JP2019522506A (en) | Storage container with implant covering guide | |
ES2621524T3 (en) | Ready to use device and method to eliminate interfering factors from samples to be subjected to microbiological examination | |
WO2019215748A1 (en) | System and method of sterilization and packaging of a medical device | |
WO2021012825A1 (en) | Endoscope sterile protective sleeve | |
EP3462860B1 (en) | Container | |
US20190289844A1 (en) | Container |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHANG, ROBERT T;MCCOLLUM, BRIAN K;CONROY, MICHAEL J;SIGNING DATES FROM 20130219 TO 20140303;REEL/FRAME:032343/0088 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551) Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |